An overview of Personal Profiles can be found at http://www.moloncol.org.
Hedvig Hricak
Chair, Department of Radiology; Carroll and Milton Petrie Chair; Memorial Sloan‐Kettering Cancer Center.
Hedvig Hricak is Chairman of the Department of Radiology at Memorial Sloan‐Kettering Cancer Center. She holds a senior position within the Program of Molecular and Pharmacology Therapeutics at the Sloan‐Kettering Institute, is a Professor at Gerstner Sloan‐Kettering Graduate School of Biomedical Sciences and is a Professor of Radiology at the Weill Medical College of Cornell University. She earned her MD degree from the University of Zagreb and her Dr. Med. Sc. from the Karolinska Institute. In 2005 she was awarded an honorary doctorate in medicine (Dr.h.c.) from Ludwig Maximilian University in Munich, Germany. Prior to joining MSKCC, she was a professor of radiology, radiation oncology, urology and gynecology at the University of California, San Francisco and was the chief of the abdominal section of the Department of Radiology at the UCSF Medical Center. She has helped develop applications in ultrasound, MR, and CT for gynecological cancers as well as MR and MR spectroscopy for prostate cancer. She continues to investigate diagnostic methods for cancer detection, staging, and management and is involved in developing clinical approaches for molecular imaging of cancer.
Dr. Hricak is a member of the Institute of Medicine (IOM) of the National Academies of Science. She serves as a member of the Nuclear Radiation Study Board of the National Academies. She is also a “foreign” member of the Croatian Academy of Arts and Sciences. Dr. Hricak serves on the committees or executive boards for a number of medical societies and served as President of the California Academy of Medicine (1999), President of the Society for the Advancement of Women's Imaging (1997–1999), President of the Society of Uroradiology (2000–2003), and President of the New York Roentgen Society (2004–2005) and President of the Radiological Society of North America (2009–2010).
Dr. Hricak has authored or co‐authored 342 peer‐reviewed original research articles, 159 review/editorial articles, 133 book chapters. She has given more than 130 named or keynote lectures and has been a visiting professor at more than 30 institutions worldwide. She has had multiple government sponsored grants throughout her career and is currently the PI on 3 NIH funded awards. She is a fellow of the American College of Radiology, the International Society for Magnetic Resonance in Medicine, and the Society of Uroradiology. In recognition of her career accomplishments, she has received the Marie Curie Award of the American Association of Women Radiologists, the gold medals of the International Society for Magnetic Resonance in Medicine and the Association of University Radiologists, the Béclère medal of the International Society of Radiology, the Morocco Medal of Merit, and the Katarina Zrinska Croatian presidential award. She is an honorary fellow of the Royal College of Radiologists and an honorary member of the British Institute of Radiology, German Radiological Society, Austrian Roentgen Society, Croatian Society of Radiology, Journées Françaises de Radiologie, Swedish Society of Medical Radiology, Chinese Radiological Society, Japanese Radiological Society, Israel Radiological Association and Indian Radiological and Imaging Association.
Elaine R. Mardis
Associate Professor of Genetics and Molecular Microbiology, Co‐director, The Genome Center at Washington University School of Medicine.
Dr. Elaine Mardis graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA.
In 1993, Dr. Mardis joined The Genome Center at Washington University School of Medicine. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the Human Genome. She currently orchestrates the Center's efforts to explore next generation and third generation sequencing technologies and to transition them into production sequencing capabilities.
Dr. Mardis has research interests in the application of DNA sequencing to characterize cancer genomes. She also is interested in facilitating the translation of basic science discoveries about human disease into the clinical setting.
Dr. Mardis serves on several NIH study sections, is an editorial board member of Genome Research, and acts as a reviewer for Nature and Genome Research. She serves as chair of the Basic and Translational Sciences Committee for the American College of Surgeons Oncology Group, a NCI funded cooperative group. She serves on the scientific advisory boards of Pacific Biosciences, Inc. and Edge Biosciences, Inc. Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics in 2010, and has been named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences for 2011.
Martine J. Piccart
Professor of Oncology at the Université Libre de Bruxelles (ULB) and Director of the Medicine Department at the Institut Jules Bordet, in Brussels, Belgium.
Dr. Piccart earned her M.D. and Ph.D. at the Université Libre de Bruxelles, Belgium, and received her oncology qualifications in New York and London. She is a member of the “Académie Royale de Médecine de Belgique”.
With a primary interest in breast cancer and drug development, Dr. Piccart has a strong interest in international research collaboration, and is the principal or co‐principal investigator of many clinical trials, including HERA, MINDACT, and ALTTO. She is co‐founder and chair of the Brussels‐based Breast International Group (BIG), created in 1996 to facilitate international breast cancer clinical trials, and TRANSBIG, a European Commission supported translational research consortium to complement BIG's clinical research network. BIG brings together 44 collaborative groups from around the world and has over 30 trials under its umbrella; TRANSBIG represents 39 institutions in 21 countries; and BIG has recently launched an innovative biomarker and drug development program focused on neo‐adjuvant trials, called NeoBIG.
Dr. Piccart is an active member of many professional organizations, currently serving as president‐elect of the European Society for Medical Oncology (ESMO). She is immediate past‐president of the European Organization for the Research and Treatment of Cancer (EORTC) and recently served on the American Society of Clinical Oncology (ASCO) Board.
She is author or co‐author of more than 300 scientific publications in peer‐reviewed journals and has received numerous prestigious awards for her contribution to research in oncology, including the ESMO Award for Exceptional Contribution to the Advancement of Medical Oncology in Europe (1997), a “Jacqueline Seroussi Memorial Foundation for Cancer Research Award” for “International leadership in translational and clinical research that has improved treatment outcomes for women with early stage and advanced breast cancer” (2005), the 14th Claude Jacquillat Award for achievements in clinical oncology (2006) and the ESMO‐GSK Lifetime Achievement Award in Breast Cancer Research (to the Breast International Group in 2006). She was awarded the “Miami Breast Cancer Conference Award of Excellence for 2007” and the Jill Rose Award for distinguished biomedical research in October 2009 in New‐York. More recently, Dr Piccart received the William L. McGuire Award in recognition of her contribution in breast cancer research in December 2009 in San Antonio.
(2011), New members of the Editorial Board, Molecular Oncology, 5, doi: 10.1016/j.molonc.2011.03.006.